IRIS
FRANCESCHINI, ROSSELLA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.961
EU - Europa 5.034
AS - Asia 2.098
SA - Sud America 423
AF - Africa 55
OC - Oceania 9
Continente sconosciuto - Info sul continente non disponibili 6
Totale 13.586
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.912
GB - Regno Unito 1.592
CN - Cina 891
RU - Federazione Russa 885
IE - Irlanda 638
SG - Singapore 635
IT - Italia 432
UA - Ucraina 410
BR - Brasile 379
SE - Svezia 344
DE - Germania 254
FR - Francia 196
HK - Hong Kong 178
FI - Finlandia 148
KR - Corea 104
VN - Vietnam 81
IN - India 46
TR - Turchia 43
CA - Canada 33
BE - Belgio 27
ES - Italia 26
BD - Bangladesh 25
PL - Polonia 19
AR - Argentina 16
IQ - Iraq 16
NL - Olanda 16
ZA - Sudafrica 14
CZ - Repubblica Ceca 13
MX - Messico 11
SA - Arabia Saudita 11
JP - Giappone 10
KE - Kenya 10
AU - Australia 8
CI - Costa d'Avorio 8
AT - Austria 7
ID - Indonesia 7
MY - Malesia 7
NP - Nepal 6
UZ - Uzbekistan 6
EC - Ecuador 5
EU - Europa 5
LY - Libia 5
MA - Marocco 5
BG - Bulgaria 4
CH - Svizzera 4
CL - Cile 4
CO - Colombia 4
IR - Iran 4
KZ - Kazakistan 4
PK - Pakistan 4
PY - Paraguay 4
TN - Tunisia 4
VE - Venezuela 4
EG - Egitto 3
JO - Giordania 3
LV - Lettonia 3
PE - Perù 3
AE - Emirati Arabi Uniti 2
BO - Bolivia 2
DZ - Algeria 2
GR - Grecia 2
HR - Croazia 2
JM - Giamaica 2
LB - Libano 2
LK - Sri Lanka 2
LT - Lituania 2
PT - Portogallo 2
RO - Romania 2
SN - Senegal 2
TH - Thailandia 2
TT - Trinidad e Tobago 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
AZ - Azerbaigian 1
BB - Barbados 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BW - Botswana 1
DK - Danimarca 1
EE - Estonia 1
ET - Etiopia 1
GE - Georgia 1
GY - Guiana 1
HU - Ungheria 1
KG - Kirghizistan 1
KH - Cambogia 1
KW - Kuwait 1
LU - Lussemburgo 1
MD - Moldavia 1
NZ - Nuova Zelanda 1
OM - Oman 1
TW - Taiwan 1
UY - Uruguay 1
Totale 13.586
Salva come PNG Salva come JPEG
Città #
Southend 1.511
Dallas 800
Dublin 636
Fairfield 562
Ashburn 477
Menlo Park 445
Singapore 356
Jacksonville 335
Chandler 324
Santa Clara 281
Woodbridge 258
Moscow 254
Beijing 251
Houston 215
Wilmington 214
Seattle 196
Cambridge 190
Hong Kong 177
Ann Arbor 172
Princeton 118
Siena 109
Nanjing 104
New York 104
Seoul 104
Helsinki 71
Hefei 70
The Dalles 67
Los Angeles 65
Munich 52
Boardman 51
Nanchang 48
Dearborn 39
San Diego 37
Buffalo 35
San Mateo 35
São Paulo 32
Hebei 29
Izmir 28
Shenyang 28
Ho Chi Minh City 26
Columbus 25
Brussels 21
London 21
Changsha 20
Council Bluffs 20
Hanoi 20
Jinan 20
Kunming 20
Rome 20
Washington 20
San Francisco 19
Turku 19
Düsseldorf 18
Shanghai 18
Málaga 17
Toronto 16
Jiaxing 15
Tianjin 15
Boston 14
Milan 14
Redondo Beach 14
Rio de Janeiro 13
Guangzhou 12
Norwalk 12
Belo Horizonte 11
Brooklyn 11
Redwood City 11
Dong Ket 10
Frankfurt am Main 10
Montreal 10
Tokyo 10
Warsaw 10
Bengaluru 9
Chicago 9
Dhaka 9
Kraków 9
Nairobi 9
Abidjan 8
Atlanta 8
Brasília 8
Brno 8
Campinas 8
Florence 8
Hangzhou 8
Taizhou 8
Bologna 7
Delhi 7
Johannesburg 7
Poplar 7
Venezia 7
Zhengzhou 7
Ankara 6
Goiânia 6
Jeddah 6
Ningbo 6
Tashkent 6
Changchun 5
Chennai 5
Kuala Lumpur 5
Lanzhou 5
Totale 9.613
Salva come PNG Salva come JPEG
Nome #
Cumulative retention rate of adalimumab in patients with Behçet's disease-related uveitis: A four-year follow-up study 330
A novel mutation producing premature termination codon at the OPA1 gene causes autosomal dominant optic atrophy. 306
The purinergic P2×7 receptor is expressed on monocytes in Behçet's disease and is modulated by TNF-α 299
Ten-Year Retention Rate of Infliximab in Patients with Behçet’s Disease-Related Uveitis 299
A novel OPA1 mutation in a family with Autosomal Dominant Optic Atrophy 297
Biological therapies for the treatment of Behçet's disease-related uveitis beyond TNF-alpha blockade: a narrative review 294
Auditory involvement in Behcet’s disease: relationship with demographic, clinical, and therapeutic characteristics 286
Efficacy of adalimumab and infliximab in recalcitrant retinal vasculitis inadequately responsive to other immunomodulatory therapies 264
Genotype-phenotype and OCT correlations in Autosomal Dominant Optic Atrophy related to OPA1 gene mutations: Report of 13 Italian families 257
Quality of life impairment in Behçet’s disease and relationship with disease activity: a prospective study 252
Cavernous malformation of the optic nerve mimicking optic neuritis 247
A difficult case: sarcoidosis with CNS involvement or sarcoidosis associated with multiple sclerosis? 234
Rapid and Sustained Efficacy of Golimumab in the Treatment of Multirefractory Uveitis Associated with Behçet’s Disease 231
Uveiti Infantili : incidenza delle varie forme e correlazione con le malattie sistemiche 230
The Presence of Uveitis Is Associated with a Sustained Response to the Interleukin (IL)-1 Inhibitors Anakinra and Canakinumab in Behçet's Disease 226
Molecular genetic study of Leber’s hereditary optic neurophaty (LHON): mutation screening by sequencing of ND1, ND4, ND%, ND6 genes 221
Predictors of sustained clinical response in patients with Behçet’s disease-related uveitis treated with infliximab and adalimumab 220
Efficacy and Safety of Adalimumab in Behçet’s disease related uveitis: a multicenter retrospective observational study 220
Correlation of Serum Amyloid-A Levels, Clinical Manifestations, Treatment, and Disease Activity in Patients with Behçet's Disease 219
Systemic Steroid Sparing Effect of Intravitreal Dexamethasone Implant in Chronic Noninfectious Uveitic Macular Edema 218
Leber's hereditary optic neuropathy associated with cocaine, ecstasy and telithromycin consumption 214
Impact of Uveitis on Quality of Life: A Prospective Study from a Tertiary Referral Rheumatology-Ophthalmology Collaborative Uveitis Center in Italy 214
Effectiveness and tuberculosis-related safety profile of interleukin-1 blocking agents in the management of Behçet's disease 205
Optic perineuritis: A further cause of visual loss and disc edema in children 205
A new Krit1 gene mutation in a family with cerebral cavernous malformation (CCM) associated with intraorbital optic nerve and cutaneous cavernous angiomas 200
Aspetti angiografici con verde di indocianina in alcune patologie oculari 198
Analysis of opa1 isoforms expression and apoptosis regulation in autosomal dominant optic atrophy (ADOA) patients with mutations in the opa1 gene 196
Leber's hereditary optic neuropathy associated with cocaine, ecstasy and telythromicin consumption 194
Citologia congiuntivale dei portatori di lenti a contatto morbide 194
IL-6 blockade in the management of non-infectious uveitis 191
In vivo confocal microscopy and anterior segment optical coherence tomography in a case of alternaria keratitis 186
The emerging role of interleukin (IL)-1 in the pathogenesis and treatment of inflammatory and degenerative eye diseases 181
The protean ocular involvement in monogenic autoinflammatory diseases: state of the art 179
Aspetti angiografici con verde di indocianina di alcune patologie oculari 177
Interleukin (IL)-1 inhibition with anakinra and canakinumab in Behçet’s disease-related uveitis: a multicenter retrospective observational study 176
Descrizione di una nuova mutazione del gene Krit1 in una forma familiare di angioma cavernoso cerebrale associata ad angioma ottico e ad angioma cutaneo 173
Inhibition of Interleukin-1 by Canakinumab as a Successful Mono-Drug Strategy for the Treatment of Refractory Behçet's Disease: A Case Series 173
Atrofie ottiche " asintomatiche" della prima infanzia: difficoltà interpretative 171
Subcortical low-intensity and restricted diffusion after first seizure in a child 169
Human herpesvirus-6B active infection associated with relapsing bilateral anterior optic neuritis 167
Esoftalmo da flogosi 165
null 165
Uveiti prevalentemente posteriori ed entità cliniche di incerta definizione 163
Vasculopatia occlusiva retinica in paziente con emoglobina SC 160
Pseudoistoplasmosi oculare da Candida: descrizione di un caso clinico 158
Serum amyloid-A in Behçet's disease 158
Successful use of canakinumab in a patient with resistant Behçet's disease 148
Irido-corneal-endothelial syndrome: a confocal and anterior segment coherent tomography differential diagnosis 146
Influenza della flogosi oculare sulla concentrazione della sisomicina nell'umore acqueo di coniglio 145
Esame con PCR sul vitreo per la diagnosi di retinite da CMV 142
Indicazioni e valutazione degli esami infettivologicici 140
Anakinra treatment in drug-resistant Behcet's disease: a case series. 139
Indagini semeiologiche nelle uveiti infantili 136
Heidelberg retina tomograph in the follow-up of papilledema 135
Intravitreal Dexamethasone Implant as an Adjunct Weapon for Severe and Refractory Uveitis in Behçet's Disease 134
null 133
Epidemiological profile of non-infectious uveitis from the rheumatologist's perspective: a survey from two tertiary referral centres in Italy 133
null 131
Serum immunoglobulin D levels in patients with Behçet's disease according to different clinical manifestations 131
Patologie dell'uvea 127
Patologie della sclera 126
Bilateral dexamethasone intravitreal implant in a young patient with Vogt-Koyanagi-Harada disease and refractory uveitis. 125
Significato del dosaggio del Retinolo e del Beta- Carotene in alcuni quadri di patologia oculare 123
null 122
null 120
Otticopatia ischemica anteriore (O.I.A.) e lesioni ischemiche cerebrali 119
Human Herpesvirus 6B active infection associated with recurrent bilteral optic neuritis 115
null 115
The pain in optic neuritis: A manifestation of visceralis hyperalgesia [Il dolore nelle neuriti ottiche: una manifestazione di iperalgesia viscerale] 114
null 113
Efficacy of anti-tumour necrosis factor-α monoclonal antibodies in patients with non-infectious anterior uveitis 111
null 107
Enhanced expression and function of the P2X7 purinergic receptor in peripheral blood mononuclear cells from patients with Behcet's disease 105
Long-lasting uveitis remission and hearing loss recovery after rituximab in Vogt-Koyanagi-Harada disease 96
Il dolore nelle cheratopatie e nelle lesioni dell’epitelio corneale 95
Update on the Medical Management of Gastrointestinal Behçet's Disease 73
Safety profile of biologic agents for Behçet's disease in a multicenter observational cohort study 61
Interleukin-1 blockade in neuro-Behçet's disease: a case-based reflection 59
Totale 13.701
Salva come PNG Salva come JPEG
Categoria #
all - tutte 37.377
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 37.377
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021832 0 0 0 0 0 181 55 208 111 106 100 71
2021/2022957 79 120 55 72 52 13 48 30 53 108 109 218
2022/20231.272 82 115 192 166 115 266 17 91 134 24 34 36
2023/20241.020 42 16 86 39 47 361 329 13 1 15 4 67
2024/20251.906 31 95 188 106 259 111 92 110 113 74 227 500
2025/20262.911 355 659 598 471 774 54 0 0 0 0 0 0
Totale 13.701